Mutua Madrileña Foundation funds a research project on personalized treatments in lung cancer

The Mutua Madrileña Foundation in its XI Call for Research Grants, has selected a project aimed at personalizing the treatment of lung cancer led by the team leader of the ICO-IDIBELL chemoresistance group, Alberto Villanueva. The project is based on the personalization of cancer treatments for non-small cell lung (NSCLC) by the generation of mouse

Mutua Madrileña Foundation funds a research project on personalized treatments in lung cancer Read More »

Xavier Bosch, among the most important scientists of the world

The agency Thomson Reuters has published the Highly Cited Researchers, a list of the most recognized in the world based on the number of citations received their education researchers. Among the 3,000 researchers from the 47 most influential disciplines are Spanish. The section on clinical medicine, meanwhile, includes 402 researchers worldwide, of which 7 are

Xavier Bosch, among the most important scientists of the world Read More »

The aecc funds a research project on lung cancer participated by IDIBELL

The Spanish Association against Cancer (AECC) has awarded aid 1 million two hundred thousand euros to identify new therapeutic targets and prognostic markers in lung tumors poorly characterized. The project has duration of five years. Lung cancer is one of the tumors having higher mortality rates worldwide. Only in Spain each year about 20,000 people

The aecc funds a research project on lung cancer participated by IDIBELL Read More »

Scroll to Top